Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with Multiple Myeloma receiving systemic anti‐cancer therapy.

Cook, G orcid.org/0000-0003-0223-3652, Ashcroft, AJ, Pratt, G et al. (13 more authors) (2020) Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with Multiple Myeloma receiving systemic anti‐cancer therapy. British Journal of Haematology. ISSN 0007-1048

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

This article is protected by copyright. This is the peer reviewed version of the following letter: Cook, G , Ashcroft, AJ, Pratt, G et al. (13 more authors) (2020) Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with Multiple Myeloma receiving systemic anti‐cancer therapy. British Journal of Haematology, which has been published in final form at https://doi.org/10.1111/bjh.16874. The article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Dates:
  • Published (online): 21 May 2020
  • Accepted: 15 May 2020
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 02 Jun 2020 10:23
Last Modified: 21 May 2021 00:38
Status: Published online
Publisher: Wiley
Identification Number: 10.1111/bjh.16874
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)